Cardiogen 20mg 10vials

Description

Cardiogen Heart Peptide Bioregulator for Cardiovascular Research

Chemical Properties

• CAS Number: 141613-31-0
• Molecular Formula: C18H30N6O10
• Molecular Weight: 502.5 Da
• Purity: >99.0% via HPLC-UV and Mass Spectrometry
• Appearance: Fine white sterile lyophilizate

How It Works

The biochemical activity of Cardiogen is defined by its ability to penetrate the cell membrane and interact directly with the chromatin structure of cardiomyocytes. The primary mechanism involves the tetrapeptide enters the nucleus and binds to specific DNA sequences to modulate methylation patterns. This defines the first semantic triple: [Cardiogen modulates DNA methylation]. Secondly, this epigenetic interaction facilitates the unwrapping of condensed chromatin, allowing for the up-regulation of genes responsible for structural protein synthesis. This establishes the second triple: [Ala-Glu-Asp-Arg activates myocardial protein synthesis]. Thirdly, Cardiogen influences the functional balance of cardiac fibroblasts, preventing excessive extracellular matrix accumulation. This forms the third triple: [Cardiogen regulates fibroblast proliferation]. Quantitatively, Cardiogen has a short systemic half-life of approximately 45 minutes, yet its epigenetic signaling effects on protein transcription can persist for weeks following a completed research cycle. Unlike Coronateric (the crude bovine-derived extract), Cardiogen is a highly purified synthetic analog that provides researchers with exact dosing control and immediate bioavailability.

Overview

Cardiogen is a synthetic tetrapeptide (Alanyl-Glutamyl-Aspartyl-Arginine) classified as a cytogen bioregulator, specifically engineered to interact with the epigenetic machinery of myocardial tissue. This signaling molecule serves as a primary tool for researchers investigating the restoration of protein synthesis in senescent or stressed heart cells.

Known Effects

• Enhanced Myocardial Resilience: Users report significant improvements in physical endurance and recovery markers in models of cardiovascular stress.
• Resolution of Fibrotic Signaling: Experimental findings suggest that the peptide assists in maintaining optimal heart wall thickness by modulating fibroblast activity.
• Optimized Microvascular Perfusion: Per experimental records, research shows improved oxygen delivery to heart tissue during intense metabolic phases.
• Normalization of Cardiac Rhythm: Multiple research groups note a stabilizing effect on cellular electrical signaling in heart tissue models.
• Synergistic Capacity: Often researched alongside Epithalamin Epithalon to investigate systemic longevity and metabolic homeostasis.

In Brief:
Cardiogen represents a high-feasibility research tool for investigating epigenetic myocardial repair and the precise modulation of heart tissue protein synthesis.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.